Monika Maria Toernsen - Sep 15, 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Commercial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
Sep 15, 2022
Transactions value $
-$2,539
Form type
4
Date filed
11/18/2022, 04:01 PM
Previous filing
Jul 11, 2022
Next filing
Jun 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PASG Common Stock Options Exercise +5K 5K Sep 15, 2022 Direct F1
transaction PASG Common Stock Sale -$2.54K -1.68K -33.62% $1.51 3.32K Sep 19, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Restricted Stock Unit Options Exercise $0 -5K -25% $0.00 15K Sep 15, 2022 Common Stock 5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.